Association between increasing maximum tumor dimension (MTD) thresholds and event-free survival in PET-negative patients randomly assigned to receive no further therapy (N = 211)
MTD threshold, mm* . | <MTD threshold . | ≥MTD threshold . | HR ≥threshold . | 95% CI . | P . | ||
---|---|---|---|---|---|---|---|
n . | Events . | n . | Events . | ||||
10 | 20 | 2 | 191 | 19 | 0.97 | 0.23-4.19 | .97 |
20 | 51 | 4 | 160 | 17 | 1.35 | 0.45-4.01 | .59 |
30 | 103 | 6 | 108 | 15 | 2.43 | 0.94-6.27 | .07 |
40 | 151 | 11 | 60 | 10 | 2.38 | 1.01-5.61 | .05 |
50 | 172 | 12 | 39 | 9 | 3.78 | 1.59-9.02 | .003 |
60 | 187 | 17 | 24 | 4 | 2.00 | 0.67-5.95 | .21 |
70 | 198 | 19 | 13 | 2 | 1.60 | 0.37-6.88 | .53 |
80 | 205 | 19 | 6 | 2 | 3.36 | 0.77-14.64 | .11 |
90 | 209 | 20 | 2 | 1 | 5.56 | 0.74-41.64 | .09 |
100 | 210 | 21 | 1 | 0 | — | — | — |
MTD threshold, mm* . | <MTD threshold . | ≥MTD threshold . | HR ≥threshold . | 95% CI . | P . | ||
---|---|---|---|---|---|---|---|
n . | Events . | n . | Events . | ||||
10 | 20 | 2 | 191 | 19 | 0.97 | 0.23-4.19 | .97 |
20 | 51 | 4 | 160 | 17 | 1.35 | 0.45-4.01 | .59 |
30 | 103 | 6 | 108 | 15 | 2.43 | 0.94-6.27 | .07 |
40 | 151 | 11 | 60 | 10 | 2.38 | 1.01-5.61 | .05 |
50 | 172 | 12 | 39 | 9 | 3.78 | 1.59-9.02 | .003 |
60 | 187 | 17 | 24 | 4 | 2.00 | 0.67-5.95 | .21 |
70 | 198 | 19 | 13 | 2 | 1.60 | 0.37-6.88 | .53 |
80 | 205 | 19 | 6 | 2 | 3.36 | 0.77-14.64 | .11 |
90 | 209 | 20 | 2 | 1 | 5.56 | 0.74-41.64 | .09 |
100 | 210 | 21 | 1 | 0 | — | — | — |
Bold text indicates chosen MTD threshold.
Small numbers of patients and events across some groups.